Entecavir plus adefovir or entecavir plus tenofovir for patients with chronic hepatitis B resistant to neucleot(s)ide analogues

被引：0
|
作者：
Park, Jung Gil [1 ]
Kweon, Young Oh [2 ]
Tak, Won Young [2 ]
Jang, Se Young [2 ]
Lee, Su Hyun [2 ]
Park, Soo Young [2 ]
机构：
[1] CHA Univ Gumi CHA Med Ctr, Gumi, South Korea
[2] Kyungpook Natl Univ, Sch Med, Taegu, South Korea
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1903
引用
收藏
页码：1116A / 1116A
页数：1
相关论文
共 50 条
  • [41] Entecavir Plus Tenofovir Combination Therapy in Patients with Multi-drug Resistant Chronic Hepatitis B: A multicenter, Prospective Study - Early Experience
    Park, Jun Yong
    Kim, Chang Wook
    Bae, Si Hyun
    Ahn, Sang Hoon
    HEPATOLOGY, 2013, 58 : 704A - 704A
  • [42] DE-NOVO ANTIVIRAL THERAPY WITH NUCLEOS(T)IDE ANALOGUES IN 'REAL-LIFE' PATIENTS WITH CHRONIC HEPATITIS B INFECTION: COMPARISON OF VIROLOGICAL RESPONSES BETWEEN LAMIVUDINE plus ADEFOVIR VS ENTECAVIR VS TENOFOVIR THERAPY
    Carey, I.
    DorothyJoe, H. Nguyen
    Al-Freah, M.
    Knighton, S.
    Bruce, M.
    Suddle, A.
    Harrison, P. M.
    Agarwal, K.
    GUT, 2011, 60 : A22 - A23
  • [43] Multiple drug-resistant HBV mutation may contribute to poor response of adefovir plus entecavir in entecavir-resistant patients
    Shao, Jinman
    Liu, Yan
    Liu, Li-Ming
    Chen, Rongjuan
    Zhao, Li
    Zhou, Yi
    Li, Le
    Li, Xiaodong
    Li, Jin
    Xu, Dongping
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (01): : 131 - +
  • [44] Comparison of clinical outcomes in cirrhotic chronic hepatitis B patients treated with Entecavir or Lamivudine plus Adefovir dipivoxil for 144 weeks
    Pan, Hong-Ying
    Pan, Hong-Yi
    Yan, Jun
    Liu, Hong
    Chen, Li
    Chen, Cui-Rong
    Jin, Jie
    Xu, Jing
    Sun, Zhen-Jiang
    Lu, De-Rong
    HEPATOLOGY, 2013, 58 : 690A - 690A
  • [45] Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B
    Guzelbulut, Fatih
    Ovunc, Ayse Oya Kurdas
    Cetinkaya, Zuleyha Akkan
    Senates, Ebubekir
    Gokden, Yasemin
    Salturk, Ayca Gokcen Degirmenci
    Sezikli, Mesut
    Ozkara, Selvinaz
    Cetinkaya, Fuat
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 477 - 480
  • [46] Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Cho, Yuri
    Lee, Yun Bin
    Yoo, Jeong-Ju
    Lee, Minjong
    Lee, Dong Hyeon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    PLOS ONE, 2015, 10 (06):
  • [47] Adefovir-Based Combination Therapy With Entecavir or Lamivudine for Patients With Entecavir-Refractory Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Lee, Dami
    Lee, Myoung Hee
    Hong, Sun Pyo
    Kim, Soo-Ok
    Cho, Sung Won
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (01) : 18 - 25
  • [48] Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
    Dogan, Umit Bilge
    Kara, Banu
    Gumurdulu, Yuksel
    Soylu, Aliye
    Akin, Mustafa Salih
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2012, 23 (03): : 247 - 252
  • [49] Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t) ide-naive patients with chronic hepatitis B
    Kwon, Y. J.
    Lee, H. S.
    Park, M. J.
    Shim, S. G.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2015, 18 (06) : 796 - 801
  • [50] Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B
    Hagiwara, Satoru .
    Nishida, Naoshi
    Ida, Hiroshi
    Ueshima, Kazuomi
    Minami, Yasunori
    Takita, Masahiro
    Komeda, Yoriaki
    Kudo, Masatoshi
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (10) : 1804 - 1810
12345